ReviewRSC advances2020
ACE2 as a potential therapeutic target for pandemic COVID-19.
Bhaswati Chatterjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewRSC advances2020
Bhaswati Chatterjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.